In today's trading, shares of Hls Therapeutics Inc opened at $4.95 and closed at $4.95. prices ranged from $4.95 to $4.95.

Shares advanced 0.61% from the previous day's close of $4.92.

Today across North America, the TSX Composite closed tsx_percentage_change% at 21807.37, the S&P 500 closed sp_500_percentage_change% at 5011.12, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37775.38 and the Nasdaq Composite closed nasdaq_percentage_change% at 15601.50.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

A total of 400 shares was traded during the session, with total trades of 4. On average, Hls Therapeutics Inc has traded 7,434 shares over the last 5-days and 9,835 year-to-date.

The TSX market on the whole today saw 2,775 price advancers against 2,424 declines and 120 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $7.12 (July 17,2023) and low as $3.34 (November 27,2023). Moreover, in the last 12 months, Hls Therapeutics Inc's shares have dipped -17.50 percent, while this year, they have advanced 25.32%.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $156.88 million on a float of 31,886 shares outstanding. Its annual EPS is $-0.85.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Based on 5.00 analysts, Hls Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. From those 5 analysts, 3 have buy ratings and 2 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..